T. Rowe Price Associates’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-52,125
Closed -$4.77M 2595
2019
Q3
$4.77M Buy
52,125
+208
+0.4% +$19K ﹤0.01% 1385
2019
Q2
$4.7M Sell
51,917
-85,903
-62% -$7.54M ﹤0.01% 1401
2019
Q1
$10.1M Buy
137,820
+1,921
+1% +$139K ﹤0.01% 1320
2018
Q4
$9.16M Sell
135,899
-3,862
-3% -$273K ﹤0.01% 1324
2018
Q3
$10.2M Sell
139,761
-1,173
-0.8% -$93.8K ﹤0.01% 1368
2018
Q2
$11.4M Buy
140,934
+576
+0.4% +$43.2K ﹤0.01% 1326
2018
Q1
$8.82M Buy
140,358
+19,610
+16% +$1.31M ﹤0.01% 1361
2017
Q4
$7.65M Buy
120,748
+9,790
+9% +$698K ﹤0.01% 1379
2017
Q3
$8.66M Sell
110,958
-300
-0.3% -$22.8K ﹤0.01% 1356
2017
Q2
$8.7M Buy
111,258
+4,905
+5% +$342K ﹤0.01% 1344
2017
Q1
$6.14M Buy
106,353
+3
+0% +$162 ﹤0.01% 1406
2016
Q4
$5.28M Buy
106,350
+5,200
+5% +$270K ﹤0.01% 1413
2016
Q3
$5.64M Sell
101,150
-16,500
-14% -$874K ﹤0.01% 1410
2016
Q2
$5.51M Buy
117,650
+710
+0.6% +$30.9K ﹤0.01% 1391
2016
Q1
$4.53M Buy
116,940
+3,100
+3% +$120K ﹤0.01% 1415
2015
Q4
$5.61M Buy
113,840
+140
+0.1% +$6.16K ﹤0.01% 1396
2015
Q3
$4.79M Buy
113,700
+7,639
+7% +$388K ﹤0.01% 1443
2015
Q2
$5.76M Sell
106,061
-2,189,000
-95% -$118M ﹤0.01% 1453
2015
Q1
$113M Sell
2,295,061
-640,088
-22% -$29.6M 0.02% 577
2014
Q4
$140M Buy
2,935,149
+319,049
+12% +$13.8M 0.03% 516
2014
Q3
$116M Sell
2,616,100
-5,300
-0.2% -$235K 0.03% 560
2014
Q2
$112M Buy
2,621,400
+1,916,100
+272% +$79.6M 0.02% 603
2014
Q1
$38.3M Buy
705,300
+385,000
+120% +$23.5M 0.01% 931
2013
Q4
$19.4M Buy
320,300
+305,900
+2,124% +$17M ﹤0.01% 1101
2013
Q3
$712K Sell
14,400
-600
-4% -$26.5K ﹤0.01% 1764
2013
Q2
$581K Buy
+15,000
New +$489K ﹤0.01% 1811

Other funds holding MDSO

T. Rowe Price Associates's MDSO Position: Q4 2019 in Review

T. Rowe Price Associates sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 52,125 shares — an estimated $4.77M sold.

T. Rowe Price Associates first reported a position in MDSO in Q2 2013 and held it in 26 quarters. The position peaked at $140M in Q4 2014. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • T. Rowe Price Associates reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • T. Rowe Price Associates sold 52,125 Medidata Solutions, Inc. shares in Q4 2019, an estimated $4.77M.
  • T. Rowe Price Associates first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 26 quarters.
  • T. Rowe Price Associates's Medidata Solutions, Inc. position peaked at $140M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.